kabutan

TAKARA BIO INC.(4974) Summary

4974
TSE Prime
TAKARA BIO INC.
887
JPY
+21
(+2.42%)
Aug 13, 3:30 pm JST
5.99
USD
Aug 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
82.1
PBR
0.98
Yield
1.92%
Margin Trading Ratio
10.32
Stock Price
Aug 13, 2025
Opening Aug 13, 9:00 am
872 JPY 5.90 USD
Previous Close Aug 12
866 JPY 5.84 USD
High Aug 13, 10:31 am
887 JPY 5.99 USD
Low Aug 13, 9:00 am
868 JPY 5.87 USD
Volume
433,300
Trading Value
0.38B JPY 2.58M USD
VWAP
881.09 JPY 5.96 USD
Minimum Trading Value
88,700 JPY 599 USD
Market Cap
0.11T JPY 0.73B USD
Number of Trades
785
Liquidity & Number of Trades
As of Aug 13, 2025
Liquidity
Slightly High
1-Year Average
531
1-Year High Feb 14, 2025
2,606
Margin Trading
Date Short Interest Long Margin Positions Ratio
Aug 8, 2025 124,000 724,000 5.84
Aug 1, 2025 135,900 784,300 5.77
Jul 25, 2025 125,900 846,300 6.72
Jul 18, 2025 108,900 920,700 8.45
Jul 11, 2025 106,500 936,200 8.79
Company Profile
TAKARA BIO INC. is a leading supplier of reagents and equipment for genetic research, with a strong focus on iPS cells and regenerative medicine. The company also offers contract services.
Sector
Chemicals
TAKARA BIO INC. operates businesses based on biotechnology, utilizing genetic engineering and cell engineering technologies. In its core reagents and equipment business, the company provides products and services for gene and cell analysis. In the contract business, TAKARA BIO INC. offers CDMO services including genetic analysis, testing, and regenerative medicine product-related contract services. In the gene therapy business, the company develops, manufactures, and sells manufacturing aids used in gene therapy drug production, and is advancing clinical development of gene therapy drugs using proprietary technologies.